Advertisement
Screener

PRAXIS PRECISION MEDICINES, INC. (PRAX) Debt Securities, Available-for-sale, Amortized Cost, Current

2.5 / 5 stars · 24/48 Roast Me

PRAXIS PRECISION MEDICINES, INC. Debt Securities, Available-for-sale, Amortized Cost, Current

PRAXIS PRECISION MEDICINES, INC. (PRAX) had Debt Securities, Available-for-sale, Amortized Cost, Current of $5.00 million as of 2023-03-31, per its 10-Q filed 2023-05-11.

Discontinued › Notes › Debt Securities, Available-for-Sale, Amortized Cost

us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostCurrent · last filed 2024-03-05

  • 2023-03-31: Debt Securities, Available-for-sale, Amortized Cost, Current $5.00M.
  • 2022-12-31: Debt Securities, Available-for-sale, Amortized Cost, Current $39.05M.
  • 2022-09-30: Debt Securities, Available-for-sale, Amortized Cost, Current $61.84M.
  • 2022-06-30: Debt Securities, Available-for-sale, Amortized Cost, Current $110.05M.
Period endDebt Securities, Available-for-sale, Amortized Cost, Current
2023-03-31$5.00M
10-Q · filed 2023-05-11
2022-12-31$39.05M
10-K · filed 2024-03-05
2022-09-30$61.84M
10-Q · filed 2022-11-09
2022-06-30$110.05M
10-Q · filed 2022-08-08
2022-03-31$133.24M
10-Q · filed 2022-05-09
2021-12-31$105.72M
10-K · filed 2023-02-07
2021-09-30$112.20M
10-Q · filed 2021-11-03
2021-06-30$114.46M
10-Q · filed 2021-08-16
2021-03-31$100.61M
10-Q · filed 2021-05-11

Similar stocks

Stock NameCountryMarket CapPE Ratio
Structure Therapeutics Inc. (GPCR)United States$7.710B-53.41
Spyre Therapeutics, Inc. (SYRE)United States$7.685B-43.69
IONIS PHARMACEUTICALS INC (IONS)United States$7.277B-23.25
TG THERAPEUTICS, INC. (TGTX)United States$8.805B19.05
Protagonist Therapeutics, Inc (PTGX)United States$8.883B95.52
Alkermes plc. (ALKS)$6.844B132.74
RHYTHM PHARMACEUTICALS, INC. (RYTM)United States$6.771B-37.20
CYTOKINETICS INC (CYTK)United States$9.130B-11.86
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)United States$9.331B-42.28
Liquidia Corp (LQDA)United States$6.347B51.23